Analysis
CXMT’s planned listing has sparked a debate about its valuation.
1
China's memory chip IPO frenzy raises big questions
2
SG's Panthera Growth Partners invests $30m in security AI firm Innefu Labs
3
Indian aluminium recycler CMR Green draws $6b bids for $66m IPO
4
China, Hong Kong investors barred from SpaceX IPO on regulatory concerns
5
Blackstone-backed Australia's AirTrunk to invest $30b in India by 2030
More Stories
French asset manager Eurazeo scouts for SE Asia bets with $20m ticket size
Jakarta prosecutors detain KoinWorks borrower in $33m irregular loan case
Vietnamese dairy firm TH Group approaches PEs for minority stake sale
ZWC Partners invests in parent of Korean eyewear label Gentle Monster
FMO proposes $20m investment in South Asia Growth Fund IV
IPOs & Markets
Foreign investment is tightly restricted or off-limits in China’s space sector.
The stock opened flat to the offer price at HK$66.4 before slipping to HK$59.05.
Hong Kong regulators have also urged banks to check investors’ sources of funds.
Capital is flowing, with a range of strategies targeting each geography.
Tsingshan Group and Lygend Resources are planning new projects in Africa.
Policy & Regulations
Brokerages Tiger and Longbridge released similar statements earlier this week.
Koru is not a typical S Korean medical aesthetics company reliant on the domestic market.
The debut comes amid a relentless surge in share sales by Chinese companies seeking to raise offshore capital.
The investment could value the company between $52b and $59b.
